Compare TAYD & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAYD | FOCL |
|---|---|---|
| Founded | 1955 | N/A |
| Country | United States | France |
| Employees | N/A | 289 |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.2M | 193.0M |
| IPO Year | 1995 | 1998 |
| Metric | TAYD | FOCL |
|---|---|---|
| Price | $61.35 | $4.14 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $70.00 | N/A |
| AVG Volume (30 Days) | 35.7K | ★ 204.7K |
| Earning Date | 03-31-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.62 | N/A |
| Revenue | $41,649,673.00 | ★ $70,527,000.00 |
| Revenue This Year | $0.25 | N/A |
| Revenue Next Year | $19.78 | N/A |
| P/E Ratio | $23.07 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $40.50 | $4.01 |
| 52 Week High | $90.37 | $6.40 |
| Indicator | TAYD | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 58.75 | 32.88 |
| Support Level | $57.54 | $4.01 |
| Resistance Level | $62.42 | $4.45 |
| Average True Range (ATR) | 1.95 | 0.19 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 71.10 | 30.61 |
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.